MAY 07, 2021 9:30 AM PDT

Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients

The pandemic hit everyone hard on many levels; now, new research from UCSF published in Cancer reports that cancer patients experienced particularly acute levels of loneliness, anxiety, depression, and fatigue due to social distancing and isolation.

"We found that oncology patients were experiencing a deep sense of loneliness," said first author Christine Miaskowski, RN, PhD, a professor in the UCSF School of Nursing.  "For these patients, the burden of their symptoms is extremely high, and oncology clinicians can suggest a number of strategies to help them," she said.

The study comes from an analysis of a survey conducted in May 2020 on 606 oncology patients. The survey assessed levels of loneliness, social isolation, anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction, and pain. The findings showed that 53% of patients reported loneliness, a number significantly higher than pre-pandemic statistics (32-47%). Within this, roughly one-third reported moderately high degrees of loneliness, and 5.3% reported high levels of depression.

Those reporting loneliness were significantly more likely to be younger people and less likely to be married or partnered. While older cancer patients reported lower levels of loneliness, patients 50 to 59 reported higher levels. Furthermore, higher levels of loneliness were also associated with higher levels of loneliness.

As the authors write, “The symptom burden of these patients is extremely high and warrants clinical evaluation and interventions.” Miaskowski comments that doctors should recommend interventions such as, "Patients should be encouraged to maintain contact with family and friends, and structure their daily routines when possible, through outdoor activities for example, as well as to maintain a healthy diet and sufficient sleep. These suggestions might mitigate some of the negative effects of loneliness."

Sources: Cancer, Eureka Alert

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 11, 2022
Cancer
Exposure to "Forever Chemical" Linked to Liver Cancer
AUG 11, 2022
Exposure to "Forever Chemical" Linked to Liver Cancer
In 1938, Dr. Roy Plunkett made an accidental discovery!  He observed tetrafluoroethylene spontaneously polymerize i ...
SEP 29, 2022
Cancer
Customer-Led Innovation: Building the CTS Xenon
SEP 29, 2022
Customer-Led Innovation: Building the CTS Xenon
How customers and R&D scientists came together across oceans and a pandemic to create a next-gen cell therapy soluti ...
SEP 26, 2022
Cancer
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
SEP 26, 2022
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...
OCT 10, 2022
Cancer
Experimental Drug Can Create Targets for Cancer-Killing Drugs
OCT 10, 2022
Experimental Drug Can Create Targets for Cancer-Killing Drugs
Immunotherapies continue to expand the cancer treatment landscape, providing new and exciting approaches to treat tumors ...
NOV 28, 2022
Clinical & Molecular DX
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
NOV 28, 2022
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc ...
NOV 29, 2022
Cancer
Some Pediatric Cancer Survivors Experience Premature Aging
NOV 29, 2022
Some Pediatric Cancer Survivors Experience Premature Aging
Aging occurs when molecular damage accumulates in cells and tissues throughout the body resulting in dysfunction and dys ...
Loading Comments...